<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Draeger A</dc:creator>
  <dc:creator>Babiychuk EB</dc:creator>
  <dc:date>2013</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The perforation of the plasmalemma by pore-forming toxins causes an influx of Ca(2+) and an efflux of cytoplasmic proteins. In order to ensure cellular survival, lesions have to be identified, plugged and removed from the membrane. The Ca(2+)-driven fusion of lysosomes with the plasma membrane leads to hydrolysis of sphingomyelin by acid sphingomyelinase and a formation of ceramide platforms in the outer leaflet of the lipid bilayer. We propose that the negative curvature, promoted by tighter packing of lipids in the outer layer, leads to an inward vesiculation of the damaged area for its endocytotic uptake and internal degradation. In contrast, the activation of neutral sphingomyelinase triggers the production of ceramide within the inner leaflet of the lipid bilayer, thereby promoting an outward curvature, which enables the cell to shed the membrane-containing toxin pore into the extracellular space. In this process, ceramide is supported by members of the annexin protein family which act as Ca(2+) sensors and as membrane fusion agents.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/138571</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/978-3-7091-1511-4_17</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/23563665</dc:relation>
  <dc:source>Handbook of experimental pharmacology. - 2013</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Cell Membrane</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Cell Survival</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Cell-Derived Microparticles</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Ceramides</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Endocytosis</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Exocytosis</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Membrane Fusion</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Mitochondria</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Pore Forming Cytotoxic Proteins</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Signal Transduction</dc:subject>
  <dc:title xmlns:ns13="xml" ns13:lang="en">Ceramide in plasma membrane repair.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
